The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence
Abstract
Objective: (1) determine which antipsychotic side effects (SE) schizophrenic patients consider the most distressing during treatment with typical antipsychotics, (2) measure the impact of actual and past SE on patients' attitude toward antipsychotics and (3) assess the influence of both on adherence. Methods: The 213 schizophrenics, treated with conventional antipsychotics, were recruited in two psychiatric hospitals in Hamburg. Subjects were assessed about type and severity of present and past side effects and their attitude and adherence to antipsychotic treatment. Results: The 82 (39%) patients presented present SE while 131 (61%) did not. Sexual dysfunctions (P<0.001), extrapyramidal (P<0.05) and psychic side effects (P<0.05) were rated as significantly subjectively more distressing than sedation or vegetative side effects. Patients presenting with present SE compared with patients without present SE had a significantly more negative general attitude toward antipsychotics (P<0.05), were more doubtful about their efficacy (P<0.01) and were less likely to encourage a relative to take such a medication in case of need (P<0.001). A regression analysis indicated that nonadherence was mainly influenced by negative general and efficacy attitudes toward antipsychotics and the experience of past or present antipsychotic side effects. Conclusions: All antipsychotic side effects, present or past, can have a durable negative impact on patient's attitude toward antipsychotic treatment and adherence. Non-adherence is mainly determined, among other factors, by these negative attitudes, which are partly influenced by the experience of past or present antipsychotic-induced side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383 · cited 3×
“[30] cite several factors that have been variously linked with adherence to medication.”
BackgroundResultAssessment of insight in psychosis
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.873 · Cited by 1,095
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 957
Compliance therapy in psychotic patients: randomised controlled trial
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996) · BMJ · doi:10.1136/bmj.312.7027.345 · Cited by 633
Why Do Schizophrenic Patients Refuse to Take Their Drugs?
Van Putten, T. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130049008 · Cited by 572
Interventions to Improve Medication Adherence in Schizophrenia
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1653 · Cited by 542
Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs
Naber, D., Moritz, S., Lambert, M., Rajonk, F., Holzbach, R., Mass, R., Andresen, B., Frank, P., Rüdiger, H., Reinhard, M., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00166-3 · Cited by 348
Self-citationThe Assessment of Insight in Psychosis
David, A., Buchanan, A., Reed, A., & Almeida, O. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.5.599 · Cited by 341
A two-year prospective study of treatment compliance in patients with schizophrenia
Buchanan, A. (1992) · Psychological Medicine · doi:10.1017/s0033291700038228 · Cited by 284
Psychological Predictors of Insight and Compliance in Psychotic Patients
Kemp, R., & David, A. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.444 · Cited by 266
Drug Refusal in Schizophrenia and the Wish to Be Crazy
Van Putten, T. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770120047004 · Cited by 260
From Noncompliance to Collaboration in the Treatment of Schizophrenia
Corrigan, P. W., Liberman, R. P., & Engel, J. D. (1990) · Psychiatric Services · doi:10.1176/ps.41.11.1203 · Cited by 251
The Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia
Allison, D. B., Mackell, J. A., & McDonnell, D. D. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.4.565 · Cited by 245
Voruganti, L., Cortese, L., Oyewumi, L., Cernovsky, Z., Zirul, S., & Awad, A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00154-1 · Cited by 226
Jeste, S. D., Patterson, T. L., Palmer, B. W., Dolder, C. R., Goldman, S., & Jeste, D. V. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00314-6 · Cited by 184
Awareness of Illness in Schizophrenia and Outpatient Treatment Adherence
CUFFEL, B. J., ALFORD, J., FISCHER, E. P., & OWEN, R. R. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199611000-00001 · Cited by 169
Indicators of medication compliance in first-episode psychosis
Kampman, O., Laippala, P., Väänänen, J., Koivisto, E., Kiviniemi, P., Kilkku, N., & Lehtinen, K. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00030-6 · Cited by 158
Factors influencing compliance in schizophrenia patients.
Fleischhacker, W. W., Oehl, M., & Hummer, M. (2003) · PubMed · Cited by 146
Larsen, E. B., & Gerlach, J. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10664.x · Cited by 136
Löffler, W., Kilian, R., Toumi, M., & Angermeyer, M. C. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-39985 · Cited by 135
Ritsner, M. S., Ponizovsky, A. M., Endicott, J., Nechamkin, Y., Rauchverger, B., Silver, H., & Modai, I. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00128-6 · Cited by 134
Donohoe, G. J., Owens, N., O’Donnell, C. P., Burke, T., Moore, L., Tobin, A., & O’Callaghan, E. (2001) · European Psychiatry · doi:10.1016/s0924-9338(01)00581-8 · Cited by 118
Beyond signs and symptoms: the case against a mixed anxiety and depression category.
Davis, J. M., Kane, J. M., Marder, S. R., Brauzer, B., Gierl, B., Schooler, N., Casey, D. E., & Hassan, M. (1993) · PubMed · Cited by 115
Attitudes Toward Antipsychotics Among Outpatient Clinic Attendees With Schizophrenia
Hofer, A., Kemmler, G., Eder, U., Honeder, M., Hummer, M., & Fleischhacker, W. W. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0110 · Cited by 100
Assertive community treatment and medication compliance in the homeless mentally ill
Dixon, L. B., Weiden, P. J., Torres, M., & Lehman, A. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1302 · Cited by 98
Cabeza, I. G., Amador, M. S., Arango, C., & de Chávez, M. G. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00079-1 · Cited by 89
Awad, A. G., Voruganti, L. N. P., Heslegrave, R. J., & Hogan, T. P. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199605002-00009 · Cited by 74
Patients?? Subjective Experiences of Antipsychotics
Hellewell, J. S. E. (2002) · CNS Drugs · doi:10.2165/00023210-200216070-00003 · Cited by 70
SUBJECTIVE ILLNESS THEORY AND ANTIPSYCHOTIC MEDICATION COMPLIANCE BY PATIENTS WITH SCHIZOPHRENIA
Holzinger, A., Löffler, W., MÜLLER, P., Priebe, S., & Angermeyer, M. C. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00004 · Cited by 67
Effect of Patient and Family Insight on Compliance of Schizophrenic Patients
Smith, C. M., Barzman, D. H., & Pristach, C. A. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04773.x · Cited by 63
Attitudes of Patients Toward the First Psychotic Episode and the Start of Treatment
de Haan, L., Peters, B. D., Dingemans, P. M. A. J., Wouters, L. F., & LINSZEN, D. H. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006951 · Cited by 61
Measurement of therapeutic response in schizophrenia
Collins, E. J., Hogan, T. P., & Desai, H. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90083-4 · Cited by 53
Kampman, O., Lehtinen, K., Lassila, V., et al. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00204-2 · Cited by 50
Insight Into Illness and Attitudes Toward Medications Among Inpatients With Schizophrenia
Sajatovic, M., Rosch, D. S., Sivec, H. J., Sultana, D., Smith, D. A., Alamir, S., Buckley, P. F., & Bingham, C. R. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.10.1319 · Cited by 49
Gervin, M., Browne, S., Garavan, J., Roe, M., Larkin, C., & O’Callaghan, E. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)00228-x · Cited by 28
Clinical correlates of akathisia in acute psychiatric inpatients
Berardi, D., Giannelli, A., & Barnes, T. R. E. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015040-00004 · Cited by 18
Brief Psychiatric Rating Scale
Hunter, E. E., & Murphy, M. (2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_1976 · Cited by 15
Cited by
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Haddad, P., Brain, C., & Scott, J. (2014) · Patient Related Outcome Measures · doi:10.2147/prom.s42735 · Cited by 585
Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications
Haddad, P. M., & Sharma, S. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721110-00004 · Cited by 456
Sexual dysfunction in schizophrenia: focus on recent evidence
Baggaley, M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.924 · Cited by 191
Bissonnette, J. M. (2008) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2008.04745.x · Cited by 172
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153
Metadata
- Authors
- Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., Golks, D., & Naber, D.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-11
- Volume
- 19
- Issue
- 7
- Pages
- 415-422
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2039549833
- Cited by
- 267
- References
- 40
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.